1. Home
  2. CW vs NTRA Comparison

CW vs NTRA Comparison

Compare CW & NTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CW
  • NTRA
  • Stock Information
  • Founded
  • CW 1929
  • NTRA 2003
  • Country
  • CW United States
  • NTRA United States
  • Employees
  • CW N/A
  • NTRA N/A
  • Industry
  • CW Industrial Machinery/Components
  • NTRA Medical Specialities
  • Sector
  • CW Technology
  • NTRA Health Care
  • Exchange
  • CW Nasdaq
  • NTRA Nasdaq
  • Market Cap
  • CW 18.5B
  • NTRA 21.7B
  • IPO Year
  • CW N/A
  • NTRA 2015
  • Fundamental
  • Price
  • CW $480.82
  • NTRA $165.60
  • Analyst Decision
  • CW Buy
  • NTRA Strong Buy
  • Analyst Count
  • CW 6
  • NTRA 16
  • Target Price
  • CW $477.50
  • NTRA $193.50
  • AVG Volume (30 Days)
  • CW 359.9K
  • NTRA 1.6M
  • Earning Date
  • CW 08-06-2025
  • NTRA 08-07-2025
  • Dividend Yield
  • CW 0.20%
  • NTRA N/A
  • EPS Growth
  • CW 16.11
  • NTRA N/A
  • EPS
  • CW 11.84
  • NTRA N/A
  • Revenue
  • CW $3,305,452,000.00
  • NTRA $1,964,250,000.00
  • Revenue This Year
  • CW $13.07
  • NTRA $23.93
  • Revenue Next Year
  • CW $6.74
  • NTRA $15.60
  • P/E Ratio
  • CW $40.61
  • NTRA N/A
  • Revenue Growth
  • CW 9.89
  • NTRA 44.38
  • 52 Week Low
  • CW $266.88
  • NTRA $110.57
  • 52 Week High
  • CW $517.09
  • NTRA $183.00
  • Technical
  • Relative Strength Index (RSI)
  • CW 47.28
  • NTRA 66.30
  • Support Level
  • CW $469.39
  • NTRA $156.71
  • Resistance Level
  • CW $511.70
  • NTRA $165.28
  • Average True Range (ATR)
  • CW 16.39
  • NTRA 6.11
  • MACD
  • CW -2.27
  • NTRA 2.20
  • Stochastic Oscillator
  • CW 30.49
  • NTRA 97.84

About CW Curtiss-Wright Corporation

Curtiss-Wright Corporation delivers engineered products and services to commercial, defence, power generation, and other industrial markets. It offers industrial vehicle components, control systems, weapons handling systems, pumps, valves, and other solutions. The company has three reportable segments based on the markets serviced: Naval & Power, which provides coolant pumps, power-dense compact motors, generators, secondary propulsion systems, pumps, pump seals, valves, control rod drive mechanisms, and fastening systems that also generate maximum revenue for the company; Its others segments are Aerospace & Industrial and Defense Electronics. Geographically, the company generates its key revenue from the United States of America, followed by the United Kingdom and other countries.

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

Share on Social Networks: